| Literature DB >> 32523979 |
Kevin Kim Jun Teh1, Shu Wen Tay1, Kaina Chen1, Samantha Jingyun Koh1, Yu Jun Wong1, Andrew Boon Eu Kwek1, James Weiquan Li1, Kwong Ming Fock1, Eng Kiong Teo1, Tiing Leong Ang1, Malcolm Teck Kiang Tan1.
Abstract
Background and study aims Using personal protective equipment (PPE) can reduce risk of disease transmission. During the COVID-19 pandemic, enhanced PPE (EPPE) is recommended when performing endoscopy. We aimed to evaluate the impact of EPPE on colonoscopy performance when compared to standard PPE (SPPE). Patients and methods A review of electronic medical records and endoscopy reports of consecutive patients who underwent colonoscopy during two similar one-month time periods (in 2019 and during the COVID-19 pandemic in 2020) was performed. SPPE was used in 2019 and EPPE was used in 2020. Patient clinical data and procedure-related information were captured and analyzed. The primary outcomes were time to cecum (TTC) and total procedure time. Secondary outcomes were adenoma detection rate (ADR), polyp detection rate (PDR) and cecal intubation rate (CIR). Statistical analysis was performed using STATA v16.1. Results Two hundred and forty-seven colonoscopy procedures were analyzed. Baseline demographics and indications for colonoscopy of patients in both groups were similar. There were no significant differences in median TTC (10.0 vs 10.0 min, P = 0.524) or total procedure time (22.5 vs 23.0 min, P = 0.946) between colonoscopy performed in SPPE and EPPE. The ADR, PDR and CIR were also similar. Conclusion Our findings suggest that use of EPPE does not affect colonoscopy performance.Entities:
Year: 2020 PMID: 32523979 PMCID: PMC7274840 DOI: 10.1055/a-1167-1703
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1 Study design.
Patient demographics.
| Variables | 2019 (SPPE) | 2020 (EPPE) |
|
| Number of patients | 116 | 131 | |
| Age (years) | 58.3 ± 13.5 | 57.0 ± 14.3 | NS |
| Gender (n,%) | |||
| Male | 55 (47.4) | 71 (54.2) | NS |
| Female | 61 (52.6) | 60 (45.8) | NS |
| Race (n,%) | |||
| Chinese | 80 (69.0) | 90 (68.7) | NS |
| Malay | 24 (20.7) | 23 (17.6) | NS |
| Indian | 5 (4.3) | 10 (7.6) | NS |
| Others | 7 (6.0) | 8 (6.1) | NS |
| BMI (kg/m 2 ) | 24.1 ± 4.3 | 24.8 ± 4.4 | NS |
| CVRF (n,%) | 73 (62.9) | 77 (58.8) | NS |
| Cardiac disease (n,%) | 14 (12.1) | 23 (17.6) | NS |
| Cerebrovascular disease (n,%) | 3 (2.6) | 7 (5.3) | NS |
| Chronic Kidney disease (n,%) | 8 (6.9) | 13 (9.9) | NS |
| Liver cirrhosis (n,%) | 3 (2.6) | 3 (2.3) | NS |
| IBD (n,%) | 4 (3.5) | 5 (3.8) | NS |
| History of abdominal surgery (n,%) | 11 (9.5) | 19 (14.5) | NS |
| Clinical Indication (n, %) | |||
| Change in bowel habit | 26 (22.4) | 28 (21.4) | NS |
| Positive fecal occult blood | 5 (4.3) | 20 (15.3) | NS |
| Rectal bleeding | 12 (10.3) | 10 (7.6) | NS |
| Pain | 22 (19.0) | 13 (9.9) | NS |
| Anemia | 24 (20.7) | 10 (7.6) | NS |
| Polyp surveillance | 11 (9.5) | 20 (15.3) | NS |
|
Others
| 16 (13.8) | 30 (22.9) | NS |
| Adequate bowel preparation (n, %) | 112 (96.6) | 124 (94.7) | NS |
Values are mean ± standard deviation or n (%)
Adequate bowel preparation is defined as Boston Bowel Prep score ≥ 2 for each colonic segment
SPPE, standard personal protective equipment; EPPE, enhanced personal protective equipment; BMI, body mass index; CVRF, cardiovascular risk factors; IBD, inflammatory bowel disease; NS, nonsignificant
Other indications include evaluation of IBD, abnormal computed tomography scan findings, elevated carcinoembryonic antigen, and loss of weight.
Results.
| Variables | 2019 (SPPE) | 2020 (EPPE) |
|
| Total number of colonoscopies | 116 | 131 | |
| Overall adenoma detection rate (%) | 21.6 | 29.8 | NS |
| Overall polyp detection rate (%) | 40.5 | 50.4 | NS |
| Cecal intubation rate (%) | 100 | 99.2 | NS |
| Time to cecum (min) | 10.0 (8.0–16.5) | 10.0 (7.0–15.0) | NS |
| Withdrawal time (min) | 10.0 (8.0–16.5) | 10.0 (10.0–18.0) | NS |
| Total procedure time (min) | 22.5 (20.0–34.5) | 23.0 (18.0–35.0) | NS |
Values for endoscopy times are expressed as median (interquartile range)
SPPE, standard personal protective equipment; EPPE, enhanced personal protective equipment; NS, nonsignificant
Results stratified according to trainee involvement .
| Variables | 2019 (SPPE) | 2020 (EPPE) |
|
| Total number of colonoscopies (n, %) | 116 (47.0) | 131 (53.0) | |
| Experienced endoscopist | 95 (81.9) | 106 (80.9) | 0.843 |
| Trainee | 21 (18.1) | 25 (19.1) | |
| Adenoma detection (n, %) | 25 (21.6) | 39 (29.8) | 0.141 |
| Experienced endoscopist | 19 (20.0) | 33 (31.1) | 0.072 |
| Trainee | 6 (33.3) | 5 (25.0) | 0.572 |
| Polyp detection (n, %) | 47 (40.5) | 66 (50.4) | 0.120 |
| Experienced endoscopist | 32 (33.7) | 55 (51.9) | 0.009 |
| Trainee | 13 (72.2) | 10 (50.0) | 0.162 |
| Cecal intubation (n, %) | 116 (100) | 130 (99.2) | 0.346 |
| Experienced endoscopist | 95 (100) | 106 (100) | |
| Trainee | 18 (100) | 19 (95.0) | 0.336 |
| Time to cecum (min) | 10.0 (8.0–16.5) | 10.0 (7.0–15.0) | 0.524 |
| Experienced endoscopist | 10.0 (7.0–15.0) | 10.0 (7.0–13.0) | 0.527 |
| Trainee | 16.0 (10.0–20.0) | 15.0 (11.0–18.5) | 0.638 |
| Withdrawal time (min) | 10.0 (8.0–16.5) | 10.0 (10.0–18.0) | 0.288 |
| Experienced endoscopist | 10.0 (8.0–15.0) | 10.0 (9.0–14.0) | 0.517 |
| Trainee | 14.5 (10.0–25.0) | 19.5 (15.5–28.5) | 0.177 |
| Total procedure time (min) | 22.5 (20.0–34.5) | 23.0 (18.0–35.0) | 0.946 |
| Experienced endoscopist | 21.0 (18.0–30.0) | 20.0 (17.0–31.0) | 0.639 |
| Trainee | 34.5 (20.0–49.0) | 34.0 (30.5–43.0) | 0.473 |
Values for endoscopy times are expressed as median (interquartile range) or n (%)
SPPE, standard personal protective equipment; EPPE, enhanced personal protective equipment